1 report

  • ITUS ENTERS INTO AGREEMENT WITH MOFFITT CANCER CENTER
  • HELIX BIOPHARMA AND MOFFITT CANCER CENTER ENTER INTO AGREEMENT
  • Cancer
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc.